Navigation Links
DrugRisk Update: Bayer Discloses $500 Million Remaining for Yaz Lawsuits

Denver, CO (PRWEB) March 13, 2013

The birth control resource center at is alerting women who have taken the contraceptives Yaz or Yasmin of new information on the site showing drug maker Bayer has spent around $1 billion so far to settle Yaz lawsuits, and has reserved a remaining $500 million to resolve new claims.

“The goal of DrugRisk is to improve the safety of those taking prescription drugs by publishing the latest warnings, recalls, studies and litigation news. Informed patients can discuss concerns with their doctor and decide if they need legal advice,” explains DrugRisk representative Ryan Mayer.

The resource center has reported that thousands of patients have filed a Yaz lawsuit, which have been consolidated to a special federal Multi-District Litigation court in Illinois. The case is known as Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois).

Injury claims came after studies from the British Medical Journal and FDA warned that birth control pills containing the hormone drospirenone, such as Yaz and Yasmin, can increase the risk of blood clots, DVT and pulmonary embolism by as much as 74%.*

DrugRisk has uncovered the latest financial reports from Bayer, which show the company faces Yaz lawsuits from as many as 13,600 claimants.** Bayer also disclosed they have spent around $1 billion so far to settle nearly 4,800 patient claims for blood clot injuries like deep vein thrombosis (DVT) or pulmonary embolism.**

Now, the resource center has learned that Bayer had set aside a total of $1.5 billion to resolve Yaz lawsuits, of which $500 million still remains to settle claims which are still pending or have yet to be filed.*** This is positive news for patients who have suffered blood clot injuries but have not filed a case.

Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism after taking Yaz or Yasmin is urged to contact the Drug Risk Resource Center or speak with a lawyer about their legal options.

Due to the specialized nature of federal MDL drug injury litigation, DrugRisk cautions that patients should seek a lawyer with experience in defective drug litigation, and only recommends lawyers and law firms who have already settled Yaz lawsuits.

For more information on the research, side effects of yaz and litigation news related to Yaz and other drugs, or to speak with a lawyer, visit

*British Medical Journal, October 25, 2011, University of Copenhagen; FDA, October 27, 2011, "Combined Hormonal Contraceptives and the Risk of Cardiovascular Disease Endpoints"
**Bayer 2012 Annual Report, Consolidated Financial Statement, Legal Notes, February 28, 2013

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Pradaxa Update: Litigation Grows As New Study Adds to Risks
2. DrugRisk Pradaxa Lawsuit Update: Court Denys Boehringer’s Protective Order Request
3. DrugRisk Update: Court Allows Charges of Prior Fraud Into Pradaxa Lawsuit
4. DrugRisk Update: NuvaRing Lawsuit Trials to Begin This Year
5. DrugRisk Announces New Pradaxa Health Warning From Australia
6. DrugRisk Adds Latest Health Warnings and Lawsuit Updates for Yaz
7. DrugRisk Announces Updated Information on Mirena Lawsuits
8. DrugRisk Announces Alternative to Mirena IUD May Be Available Soon
9. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
10. Tylenol Liver Failure Allegation Lawsuits Update: Resource4thePeople Reports Hearing to Consolidate Federal Cases Is Scheduled
11. Yasmin Blood-Clotting Lawsuits Update: Resource4thePeople Providing Legal Assistance as Concerns Rise Over Health Risks
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... Brenntag ... exclusive channel partner for the Nutraceutical Specialties products into oral solid dosage in ... immediately. , “We are pleased to announce our expanded distribution agreement with ...
(Date:11/30/2015)... , ... November 30, 2015 , ... An inventor from ... in the womb. "My last baby had high blood pressure due to loud noises," ... to protect their babies from noise pollution as well as radio waves and microwaves." ...
(Date:11/30/2015)... ... November 30, 2015 , ... Since its inception, ... in independent living, assisted living and all other retirement options. Support for issues ... and research remains a top priority. , So it’s no surprise that ...
(Date:11/30/2015)... ... 30, 2015 , ... Sikka Software announced today that they are showcasing the ... to make complex business decisions by providing the tools and information they need to ... with 10 procedures customized by zip code. , The Sikka Software Ecosystem includes ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... the assets of DataTrade Solutions Inc., a Healthcare IT consulting, development and support ... the programming and technical experience available within DataTrade to extend the services currently ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... NEW YORK , November 27, 2015 ... health system is set to go online. The potential ... and processes is vast and far from fully exploited ... access to patient health records, either via mobile tablet ... ) --> ) ...
(Date:11/27/2015)... PHILADELPHIA , Nov. 27, 2015  Lannett ... that it has completed the acquisition of Kremers ... pharmaceuticals subsidiary of global biopharmaceuticals company UCB S.A. ... --> Lannett has acquired KU from UCB ... to certain adjustments, including a customary working capital ...
(Date:11/27/2015)... 2015 ... "2016 Global Tumor Marker Testing Market: ... Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, ... their offering. --> ) ... "2016 Global Tumor Marker Testing Market: Supplier ...
Breaking Medicine Technology: